PHENOTYPIC CHARACTERIZATION OF PACLITAXEL-INDUCED PERIPHERAL NEUROPATHY IN CANCER SURVIVORS

CONTEXT: While paclitaxel is one of the most commonly used drugs to treat breast, ovarian, and lung cancers, little is known about the impact of paclitaxel-induced peripheral neuropathy (PIPN) on cancer survivors. OBJECTIVES: The purposes of this study were to evaluate for differences in demographic...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Pain Symptom Manage
Egile Nagusiak: Kober, Kord M., Mazor, Melissa, Abrams, Gary, Olshen, Adam, Conley, Yvette P., Hammer, Marilyn, Schumacher, Mark, Chesney, Margaret, Smoot, Betty, Mastick, Judy, Paul, Steven M., Levine, Jon D., Miaskowski, Christine
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2018
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6289693/
https://ncbi.nlm.nih.gov/pubmed/30172061
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpainsymman.2018.08.017
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak